CD8A and neoplasm: Reduction of 50% of Treg cells resulted in a better prognostic value by a significant reduction in the tumor load, which was associated with an increased percentage of both CD4+ and CD8+ T-activated cells in MLN in CAC mice receiving immunotherapy with the monoclonal antibody PC61.